Boland, Genevieve M <br/><br/>
Clinical next generation sequencing to identify actionable aberrations in a phase I program.  [electronic resource] 

 -  Oncotarget  Aug 2015 
 - 20099-110 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.4040  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>High-Throughput Nucleotide Sequencing--methods<br/>Humans<br/>Mutation<br/>Neoplasms--genetics<br/>Precision Medicine--methods